Coronary Artery Disease Clinical Trial
Official title:
Influence of Training Intensity on Exercise Capacity and Risk Profile in Coronary Artery Disease
Verified date | February 2018 |
Source | Hasselt University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Coronary artery disease (CAD) is associated with high mortality worldwide. Narrowing of the
coronary arteries can cause an acute myocardial infarction. Patient with cardiac ischemia are
often treated with percutaneous coronary intervention (PCI) or coronary artery bypass
grafting (CABG). Following hospitalisation, the patients are offered to attend a classical
rehabilitation program with moderate exercise intensity. Current exercise program for cardiac
rehabilitation has proven to reduce cardiovascular risk factors 1. Is it possible to improve
the exercise capacity and risk profile even more if the exercise program includes more
vigorous training? The program starts one week after the cardiac incident (AMI, PCI or CABG)
and takes 12 weeks to complete. Patients with heart failure and valvular disease are
excluded. First ventilatory threshold (VT1) and second ventilatory threshold (VT2) are
determined during cycloerometry. VT2 reflects aerobic-anaerobic transition and therefore the
aerobic functional capacity2. Exercise load reached at VT2 is used to determine the training
load during rehabilitation.
The research goal is to investigate the influence of training intensity on the exercise
capacity and risk profile of CAD patients.
Status | Completed |
Enrollment | 343 |
Est. completion date | September 15, 2017 |
Est. primary completion date | July 1, 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 25 Years to 90 Years |
Eligibility |
Inclusion Criteria: - Patients with acute myocardial infarction (AMI), who underwent a percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG). The 12-week program must be completed. Exclusion Criteria: - Patients with heart failure (HFpEF and HFrEF with ejection fraction =40%) and valvular heart disease. |
Country | Name | City | State |
---|---|---|---|
Belgium | Jessa Ziekenhuis | Hasselt |
Lead Sponsor | Collaborator |
---|---|
Hasselt University | Jessa Hospital |
Belgium,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | exercise capacity | The primary endpoint is the relationship between the actual training load (W) and exercise capacity (VO2max) obtained at the end of the rehabilitation. | up to week 12 | |
Secondary | cardiovascular risk profile | The secondary endpoint is the relationship between relative training load and the cardiovascular risk factors. | up to week 12 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06030596 -
SPECT Myocardial Blood Flow Quantification for Diagnosis of Ischemic Heart Disease Determined by Fraction Flow Reserve
|
||
Completed |
NCT04080700 -
Korean Prospective Registry for Evaluating the Safety and Efficacy of Distal Radial Approach (KODRA)
|
||
Recruiting |
NCT03810599 -
Patient-reported Outcomes in the Bergen Early Cardiac Rehabilitation Study
|
N/A | |
Recruiting |
NCT06002932 -
Comparison of PROVISIONal 1-stent Strategy With DEB Versus Planned 2-stent Strategy in Coronary Bifurcation Lesions.
|
N/A | |
Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
Recruiting |
NCT05308719 -
Nasal Oxygen Therapy After Cardiac Surgery
|
N/A | |
Recruiting |
NCT04242134 -
Drug-coating Balloon Angioplasties for True Coronary Bifurcation Lesions
|
N/A | |
Completed |
NCT04556994 -
Phase 1 Cardiac Rehabilitation With and Without Lower Limb Paddling Effects in Post CABG Patients.
|
N/A | |
Recruiting |
NCT05846893 -
Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease
|
N/A | |
Recruiting |
NCT06027788 -
CTSN Embolic Protection Trial
|
N/A | |
Recruiting |
NCT05023629 -
STunning After Balloon Occlusion
|
N/A | |
Completed |
NCT04941560 -
Assessing the Association Between Multi-dimension Facial Characteristics and Coronary Artery Diseases
|
||
Completed |
NCT04006288 -
Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease
|
Phase 4 | |
Completed |
NCT01860274 -
Meshed Vein Graft Patency Trial - VEST
|
N/A | |
Recruiting |
NCT06174090 -
The Effect of Video Education on Pain, Anxiety and Knowledge Levels of Coronary Bypass Graft Surgery Patients
|
N/A | |
Terminated |
NCT03959072 -
Cardiac Cath Lab Staff Radiation Exposure
|
||
Completed |
NCT03968809 -
Role of Cardioflux in Predicting Coronary Artery Disease (CAD) Outcomes
|
||
Recruiting |
NCT05065073 -
Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography
|
Phase 4 | |
Recruiting |
NCT04566497 -
Assessment of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up.
|
N/A | |
Completed |
NCT05096442 -
Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Korean Patients With Coronary De Novo Lesions
|
N/A |